IDO inhibitors can also be combined with other pharmacological agents to enhance their effects; for instance, IDO inhibitors have been shown to enhance the anti-tumor effects of TMZ in a mouse glioma model (21) (Figure 1). Here, IDO1 is linked to central nervous system cancer.